Skip to content
Screener

Accrued Expenses at other companies

Danaher logo
DanaherDHR
$4.87B+6.7%
Azenta logo
AzentaAZTA
$30.97M
Agilent Technologies logo
Agilent TechnologiesA
$298M-20.3%
Illumina logo
IlluminaILMN
$848M+296%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
$6.08M+22.4%
10x Genomics, Inc. logo
10x Genomics, Inc.TXG
$21.51M-2.1%

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$7.21B+361%
Enterprise value$7.2B+396%
P/S17.6×+13.3×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(In thousands, except per share data)March 31,2026September 30,2025
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$14,682$11,094
Accrued compensation27,00331,288
Current portion of operating lease liability10,44313,822
Accrued expenses and other current liabilities67,84835,202
Total current liabilities$119,976$91,406
Operating lease liability, net of current portion85,39861,750

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's accrued expenses?
Twist Bioscience Corporation (TWST) reported accrued expenses of $27M in Q1 2026.
How has Twist Bioscience Corporation's accrued expenses changed year-over-year?
Twist Bioscience Corporation's accrued expenses increased by 8.4% year-over-year, from $24.92M to $27M.
What is the long-term trend for Twist Bioscience Corporation's accrued expenses?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's accrued expenses has grown at a 8.8% compound annual growth rate (CAGR), from $22.33M to $31.29M.
What does accrued expenses mean?
Expenses incurred but not yet paid or invoiced — interest accruals, tax accruals, warranty reserves, and other timing differences.

Ask your AI about Twist Bioscience Corporation's accrued expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude